- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03462472
Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD
March 5, 2018 updated by: Salisbury University
The Acute Effects of Leg Heating and Transcutaneous Electrical Nerve Stimulation on Leg Blood Flow and Functional Capacity in Those With Peripheral Arterial Disease
Peripheral arterial disease (PAD) is characterized by poor circulation in the lower extremities that often provokes claudication (leg pain, numbness, and heaviness) with physical exertion.
The aim of this research protocol is to determine the effect of two non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD.
Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation (TENS).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Salisbury, Maryland, United States, 21801
- Recruiting
- Salisbury University
-
Contact:
- Tom Pellinger, Ph.D.
- Phone Number: 410-677-0144
- Email: tkpellinger@salisbury.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Intermittent claudication (Fontaine Stage II)
- Resting ankle-brachial index (ABI) < 0.90
- Ability to walk > 60 meters in six minutes
Exclusion Criteria:
- Body mass index (BMI) > 35 kg/m2
- Severe exercise limitations (more than PAD) due to co-morbidity
- Taking illegal/recreational drugs
- Uncontrolled hypertension (>180/100 mmHg)
- Severe peripheral neuropathy
- Foot ulcers
- Gangrene
- Pregnant or breast feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: 15 minute lower leg heating
|
Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius
|
|
Experimental: 45 minute lower leg heating
|
Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius
|
|
Experimental: 15 minute lower leg TENS
|
Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction
|
|
Experimental: 45 minute lower leg TENS
|
Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance walked during six-minute walk test
Time Frame: 35 minutes post-intervention/control
|
Distance walked during a self-paced six-minute walk
|
35 minutes post-intervention/control
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Popliteal artery blood flow
Time Frame: Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
|
Unilateral popliteal blood flow measured via Doppler ultrasound
|
Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
|
|
Time/distance to claudication during six-minute walk
Time Frame: 35 minutes following each intervention and control period
|
Subjects give subjective ratings of claudication onset, if applicable, during six-minute walk test
|
35 minutes following each intervention and control period
|
|
Ankle brachial index (ABI)
Time Frame: Pre-intervention baseline and 20 minutes post-intervention/control
|
Systolic blood pressures (SBP) are measured in the brachial arteries of both arms and in the posterior tibial and dorsalis pedis arteries of both ankles using a hand-held Doppler ultrasound probe and a sphygmomanometer
|
Pre-intervention baseline and 20 minutes post-intervention/control
|
|
Toe oxygen saturation
Time Frame: Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
|
A pulse oximeter is used to measure toe oxygen saturation in the big toe of each of the subject's feet
|
Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas K. Pellinger, Ph.D., Salisbury University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2015
Primary Completion (Anticipated)
June 1, 2018
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
February 13, 2018
First Submitted That Met QC Criteria
March 5, 2018
First Posted (Actual)
March 12, 2018
Study Record Updates
Last Update Posted (Actual)
March 12, 2018
Last Update Submitted That Met QC Criteria
March 5, 2018
Last Verified
March 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11112015-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
Marissa JarosinskiTerminatedPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Wroclaw Medical UniversityPoznan University of Medical Sciences; Military Institute of Medicine National...RecruitingPeripheral Arterial Disease(PAD)Poland
-
BayerCompleted
-
University of NebraskaRecruitingPeripheral Arterial Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Peripheral Artery Occlusive DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
Clinical Trials on Lower leg heating
-
University of Texas Southwestern Medical CenterRecruiting
-
Riphah International UniversityCompleted
-
Seoul National University HospitalCompletedMyocardial Infarction | Stable Angina | Unstable Angina | Triple Vessel DiseaseKorea, Republic of
-
University of Texas Southwestern Medical CenterCompleted
-
University of ExeterCompleted
-
University of OxfordCompletedParkinson's DiseaseUnited Kingdom
-
Milton S. Hershey Medical CenterCompleted
-
University of Missouri-ColumbiaCompletedObesity | Type 2 Diabetes MellitusUnited States
-
University of British ColumbiaHeart and Stroke Foundation of CanadaCompletedCerebrovascular Accident (Stroke)Canada